Literature DB >> 33363651

THE EXPRESSION OF STEM CELL MARKERS (CD133, NESTIN, OCT4, SOX2) IN INVASIVE PITUITARY ADENOMAS.

R Basaran1, D Gundogan2, M Senol3, C Bozdogan4, F Gezen5, A Sav6.   

Abstract

INTRODUCTION: The pituitary gland serves as the center of the endocrine system. Stem cells are typically found in a specialized microenvironment of the tissue, called the niche, which regulates their maintenance, self-renewal, fate determination, and reaction to external influences. The aim of this study is to elucidate the role of stem cells in the initiation, invasion, and progression of pituitary adenomas.
MATERIALS AND METHODS: All specimens were collected between January 2007 and April 2015. Radiological classification (invasiveness) for all cases was performed according to the Wilson-Hardy classification system. Immunohistochemical staining was performed to all specimens for CD133, Oct4, Sox2 and nestin.
RESULTS: The study included 48 patients. Of 48 patients, 17 (35.4%) were male and 31 (64.6%) were female. Mean age is 47.10±14.14 (17-86 yrs.). According to the Wilson-Hardy classification system, 27 (56.3%) were non-invasive adenomas. There was no statistical significance between the expression of pituitary stem cell markers (CD133, OCT4, SOX2, nestin) and invasiveness.
CONCLUSION: All stem cell markers are stained extensively in pituitary adenomas, except for SOX2 which was stained weakly. However, there is no effect of stem cells on invasiveness of pituitary adenomas because we cannot find a difference of the staining level between invasive and non-invasive adenomas. Nestin was stained extensively in functional adenomas, especially for GH, PRL, and gonadotropin secreting adenomas. SOX2 was stained extensively for ACTH-secreting adenomas. ©by Acta Endocrinologica Foundation.

Entities:  

Keywords:  CD133; Nestin; OCT4; SOX2; invasive; pituitary adenoma; stem cell

Year:  2020        PMID: 33363651      PMCID: PMC7748225          DOI: 10.4183/aeb.2020.303

Source DB:  PubMed          Journal:  Acta Endocrinol (Buchar)        ISSN: 1841-0987            Impact factor:   0.877


  45 in total

Review 1.  Stem cells in the pituitary gland: A burgeoning field.

Authors:  Hugo Vankelecom; Lies Gremeaux
Journal:  Gen Comp Endocrinol       Date:  2009-11-14       Impact factor: 2.822

2.  A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning.

Authors:  S Miraglia; W Godfrey; A H Yin; K Atkins; R Warnke; J T Holden; R A Bray; E K Waller; D W Buck
Journal:  Blood       Date:  1997-12-15       Impact factor: 22.113

Review 3.  A tridimensional view of pituitary development and function.

Authors:  Patrice Mollard; David J Hodson; Chrystel Lafont; Karine Rizzoti; Jacques Drouin
Journal:  Trends Endocrinol Metab       Date:  2012-03-20       Impact factor: 12.015

4.  Isolation and characterization of progenitor mesenchymal cells in human pituitary tumors.

Authors:  M Orciani; S Davis; G Appolloni; R Lazzarini; M Mattioli-Belmonte; R A Ricciuti; M Boscaro; R Di Primio; G Arnaldi
Journal:  Cancer Gene Ther       Date:  2014-12-19       Impact factor: 5.987

Review 5.  Invasive, atypical and aggressive pituitary adenomas and carcinomas.

Authors:  Aydin Sav; Fabio Rotondo; Luis V Syro; Antonio Di Ieva; Michael D Cusimano; Kalman Kovacs
Journal:  Endocrinol Metab Clin North Am       Date:  2014-11-04       Impact factor: 4.741

6.  Evidence of brain tumor stem progenitor-like cells with low proliferative capacity in human benign pituitary adenoma.

Authors:  Lingchao Chen; Hongxing Ye; Xiaomei Wang; Xuqung Tang; Ying Mao; Yao Zhao; Zhebao Wu; Xiao Ou Mao; Lin Xie; Kunlin Jin; Yu Yao
Journal:  Cancer Lett       Date:  2014-04-13       Impact factor: 8.679

Review 7.  Aggressive pituitary adenomas--diagnosis and emerging treatments.

Authors:  Antonio Di Ieva; Fabio Rotondo; Luis V Syro; Michael D Cusimano; Kalman Kovacs
Journal:  Nat Rev Endocrinol       Date:  2014-05-13       Impact factor: 43.330

8.  Expression and Prognostic Value of Oct-4 in Astrocytic Brain Tumors.

Authors:  Jeanette Krogh Petersen; Per Jensen; Mia Dahl Sørensen; Bjarne Winther Kristensen
Journal:  PLoS One       Date:  2016-12-28       Impact factor: 3.240

9.  SOX2 plays a critical role in the pituitary, forebrain, and eye during human embryonic development.

Authors:  Daniel Kelberman; Sandra C P de Castro; Shuwen Huang; John A Crolla; Rodger Palmer; John W Gregory; David Taylor; Luciano Cavallo; Maria F Faienza; Rita Fischetto; John C Achermann; Juan Pedro Martinez-Barbera; Karine Rizzoti; Robin Lovell-Badge; Iain C A F Robinson; Dianne Gerrelli; Mehul T Dattani
Journal:  J Clin Endocrinol Metab       Date:  2008-02-19       Impact factor: 5.958

10.  Mutations within Sox2/SOX2 are associated with abnormalities in the hypothalamo-pituitary-gonadal axis in mice and humans.

Authors:  Daniel Kelberman; Karine Rizzoti; Ariel Avilion; Maria Bitner-Glindzicz; Stefano Cianfarani; Julie Collins; W Kling Chong; Jeremy M W Kirk; John C Achermann; Richard Ross; Danielle Carmignac; Robin Lovell-Badge; Iain C A F Robinson; Mehul T Dattani
Journal:  J Clin Invest       Date:  2006-08-24       Impact factor: 14.808

View more
  1 in total

1.  Application of "mosiac sign" on T2-WI in predicting the consistency of pituitary neuroendocrine tumors.

Authors:  Ding Nie; Peng Zhao; Chuzhong Li; Chunhui Liu; Haibo Zhu; Songbai Gui; Yazhuo Zhang; Lei Cao
Journal:  Front Surg       Date:  2022-07-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.